It was reported, a leak was noted in three,three-way plastic stopcocks from two different lots during the same patient procedure.A transarterial chemoembolization (tace) procedure was being performed.The physician was attempting to mix an anticancer drug and contrast medium by utilizing the three-way plastic stopcock, when leakage through a crack in the stopcock was confirmed (this report).Two additional three-way plastic stopcocks (reference medwatch 1820334-2018-02120), were then utilized and both presented with cracks and leakage as well.Subsequently, the physician successfully completed the procedure without using a three-way plastic stopcock.The patient did not experience any adverse effect due to this occurrence.Per the complainant, the complaint device will not be returned to the manufacturer for investigation.It was discarded at the user facility.After the event, multiple unopened three-way plastic stopcock packages from the same lot as the first device used were opened for inspection.Cracks were noted by the customer in these devices as well.(reference medwatch 1820334-2018-02267).These were not used in any procedure and will be returned for investigation.
|
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Investigation ¿ evaluation.A review of the complaint history, device history record, documentation, drawing, manufacturing instructions, and quality control of the device was conducted during the investigation.The complaint device was not returned; therefore, no physical examinations could be performed.However, a document based investigation evaluation was performed.There is no evidence to suggest the product was not made to specifications.A review of the device history record shows no nonconforming events which could contribute to this failure mode.It should be noted there were no other reported complaints for this lot number.Based on the information provided, no product returned and the results of our investigation, a definitive root cause could not be determined.Measures are being conducted to address this failure mode.We will continue to monitor for similar complaints.Per the quality engineering risk assessment no further action is required.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|